616 related articles for article (PubMed ID: 5132824)
21. Mechanisms of pennicillamine and zinc in the treatment of Wilson's disease.
Farinati F; Cardin R; Mestriner C; Sturniolo GC; Naccarato R
Am J Gastroenterol; 1995 Dec; 90(12):2264-5. PubMed ID: 8540540
[No Abstract] [Full Text] [Related]
22. Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report.
Haslam RH; Sass-Kortsak A; Stout W; Berg M
Dev Pharmacol Ther; 1980; 1(5):318-24. PubMed ID: 7438976
[TBL] [Abstract][Full Text] [Related]
23. [On the therapeutic combination of S-adenosylmethionine with D-penicillamine in Wilson's disease].
Gasbarrini G; Miglio F; Corazza GR; Stefanini GF
Minerva Med; 1975 May; 66(33):1600-4. PubMed ID: 1143693
[TBL] [Abstract][Full Text] [Related]
24. [True hepatic Wilson's disease].
Ciravegna B; Giacchino R; Marazzi MG
Pediatr Med Chir; 1983; 5(1-2):7-10. PubMed ID: 6634446
[TBL] [Abstract][Full Text] [Related]
25. [Long-term D-penicillamine therapy of Wilson's disease in childhood. Changes in blood coagulation and effects on the haematopoetic system].
Hayek HW; Schnack H; Widhalm S
Wien Klin Wochenschr; 1973 Feb; 85(8):122-5. PubMed ID: 4632215
[No Abstract] [Full Text] [Related]
26. [Penicillamine treatment of Wilson's disease].
Falkmer S; Samuelson G; Sjölin S
Lakartidningen; 1969 May; 66(20):2097-105. PubMed ID: 5795695
[No Abstract] [Full Text] [Related]
27. The effect of long-term treatment with d-penicillamine on the humoral immune response in patients with Wilson's disease.
Czlonkowska A
Mater Med Pol; 1976; 8(1):48-50. PubMed ID: 1263584
[No Abstract] [Full Text] [Related]
28. The renal clearance of amino acids in a patient with Wilson's disease during penicillamine treatment.
Bell GE; Slivka DC; Huston JR
J Lab Clin Med; 1968 Jan; 71(1):113-21. PubMed ID: 5634999
[No Abstract] [Full Text] [Related]
29. Pregnancy in penicillamine-treated patients with Wilson's disease.
Scheinberg IH; Sternlieb I
N Engl J Med; 1975 Dec; 293(25):1300-2. PubMed ID: 1186824
[No Abstract] [Full Text] [Related]
30. [Recent findings in the therapy of Wilson's disease].
Rigardetto R; Trevisio A
Minerva Pediatr; 1975 Feb; 27(3):177-86. PubMed ID: 1226193
[No Abstract] [Full Text] [Related]
31. [Contribution to the clarification of the pathogenesis of osteopathies in Wilson's disease. (Hepatolenticular degeneration)].
Vokrouhlická-RösslerovI ; Vodicková L; Neruda O
Vnitr Lek; 1967 Oct; 13(10):1018-22. PubMed ID: 5630545
[No Abstract] [Full Text] [Related]
32. [Pemphigus in a patient treated with penicillamine for Wilson's disease].
Degos R; Touraine R; Belaïch S; Revuz J
Bull Soc Fr Dermatol Syphiligr; 1969; 76(6):751-3. PubMed ID: 5384189
[No Abstract] [Full Text] [Related]
33. [Wilson's disease (hepatolenticular degeneration)].
Ferrer S; Grismali J; Vergara F; Madrid R; Colombo M
Rev Med Chil; 1968 Dec; 96(12):779-88. PubMed ID: 5732518
[No Abstract] [Full Text] [Related]
34. [Current problems of Wilson's disease (hepatolenticular degeneration)].
Julesz J; Bodor F; Szarvas F
Orv Hetil; 1969 Dec; 110(49):2857-60. PubMed ID: 5364763
[No Abstract] [Full Text] [Related]
35. [D-penicillamine and cutaneous lesions in Wilson's disease].
Peiró Grasa A; Barnadas Andiñach M; Moreno Carazo A; Grau-Veciana JM
Neurologia; 1986; 1(2):88-9. PubMed ID: 2978898
[No Abstract] [Full Text] [Related]
36. Hepatolenticular degeneration (Wilson's disease).
Wis Med J; 1970 Mar; 69(3):105-10. PubMed ID: 5434427
[No Abstract] [Full Text] [Related]
37. [Wilson's disease (experience of long-term treatment with penicillamine---con penicilamina].
Escartín Marín P; García Plaza A; Chantar Barrios C
Rev Clin Esp; 1974 Jun; 133(5):451-4. PubMed ID: 4215106
[No Abstract] [Full Text] [Related]
38. [Favorable results with an association of L-dopa and amantadine added to penicillamine in the treatment of Wilson's disease].
Berio A; Vento R; Di Stefano A
Minerva Pediatr; 1973 May; 25(18):807-13. PubMed ID: 4732090
[No Abstract] [Full Text] [Related]
39. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
Goldstein NP; Tauxe WN; McCall JT; Gross JB; Randall RV
Trans Am Neurol Assoc; 1969; 94():34-7. PubMed ID: 5374484
[No Abstract] [Full Text] [Related]
40. Neuromuscular transmission and acetylcholine receptor antibodies in penicillamine-treated Wilson's disease patients.
Anlar B; Kuruoğlu R; Varli K; Topçu M
Muscle Nerve; 1996 May; 19(5):676-7. PubMed ID: 8618573
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
